SCHEMBL7980445

SCHEMBL7980445

O[C@@]1(c2ccc(F)cc2)CCCO1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 4/20 0.38
SLC6A2 P23975 2/20 0.38
CHRNA1 P02708 1/20 0.38
CHRNG P07510 1/20 0.38
CHRNB1 P11230 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
CHRND Q07001 1/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
HSD11B1 P28845 1/20 0.38
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
RAD52 P43351 1/20 0.37
RECQL P46063 1/20 0.37
SLC18A3 Q16572 1/20 0.37
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29941731 0.80 CYP1A2 (0.51) ALDH1A1CYP1A2CYP3A4
SCHEMBL109994 0.74 CYP1A2 (0.50) CYP1A2
SCHEMBL9017957 0.74 NPC1 (0.41) ALDH1A1CYP1A2CYP3A4
SCHEMBL7388625 0.72 ITGB1 (0.44) CYP3A4HSD11B1HDAC6
SCHEMBL25281081 0.69 SLC6A3 (0.42) SLC6A3SLC6A2HSD11B1SLC6A4MAOA
SCHEMBL21575093 0.69 HDAC6 (0.47) SLC6A3SLC6A2CYP1A2CYP3A4HSD11B1
SCHEMBL21574977 0.69 ACHE (0.45) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL21575094 0.69 HDAC6 (0.44) SLC6A3SLC6A2ALDH1A1HSD11B1HDAC6
SCHEMBL18306930 0.69 OPRM1 (0.50) SLC6A3SLC6A2HSD11B1POLBSLC6A4
SCHEMBL6154699 0.69 OPRM1 (0.50) SLC6A3SLC6A2HSD11B1POLBSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201016-B1 IMMUNOSUPPRESSANT AS 5-LIPOXYGENASE INHIBITOR AND/OR AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST CYTOMED INCORPORATED 2001-03-13 US disclosed